Al-Faraaz Kassam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Al-Faraaz Kassam has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
- Ralph Cutler Quillin
Cincinnati Research in Outcomes and Safety in Surgery (CROSS) Research Group, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
10 shared publications Alexander R. Cortez
Cincinnati Research in Outcomes and Safety in Surgery Research Group, Department of Surgery, University of Cincinnati College of Medicine, OH https://twitter.com/AlexCortezMD
9 shared publicationsLeah K. Winer
Department of Surgery, University of Cincinnati, Cincinnati, OH, USA
6 shared publications- Manuj Mayank Shah
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
4 shared publications - Aaron M. Delman
Cincinnati Research in Outcomes and Safety in Surgery (CROSS) Research Group, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
3 shared publications - Dennis M. Vaysburg
Department of Surgery Cincinnati Research and Education in Surgical Training (CREST) University of Cincinnati Cincinnati Ohio USA
3 shared publications
Latest Publications
- Open Access
Renal Trajectory of Eligible Simultaneous Liver–Kidney Transplant Recipients
Purpose: Simultaneous liver–kidney transplantation (SLK) eligible candidates may receive SLK or liver-alone transplant (LA) with access to kidney transplant after initial LA (KAL). We aimed to characterize SLK-eligible recipient outcomes according to treatment approach. Methods: This study utilized 2017–2023 SRTR data to identify SLK-eligible deceased donor liver transplants. Recipients were placed into two groups based on whether SLK was performed; non-SLK patients were sub-stratified into LA and KAL cohorts. After baseline comparisons, 2-year patient and graft survival outcomes were characterized by univariable and multivariable Cox proportional hazard regression and Kaplan–Meier analysis. Results: Among 4879 candidates identified, 3746 (76.8%) underwent SLK, 1023 (21.0%) LA, and 110 (2.3%) KAL. SLK recipients maintained the highest eGFRs at 6 months, 1 year, and 2 years post-transplant (p < 0.01). Compared to SLK recipients, non-SLK recipients had a higher 2-year risk of mortality (aHR 2.46, p < 0.01), all-cause events (aHR 1.91, p < 0.01), and liver graft failure (HR 1.55, p = 0.02). LA conferred a higher 2-year mortality risk (aHR 2.98, p < 0.01) and all-cause event risk (aHR 2.25, p < 0.01), while KAL had comparable mortality risk to SLK (aHR 0.43, p = 0.40). Conclusions: When SLK-eligible candidates undergo transplants, SLK remains the optimal path forward, even when a safety net kidney can be performed.
Open AccessRenal Trajectory of Eligible Simultaneous Liver–Kidney Transplant Recipients
Purpose: Simultaneous liver–kidney transplantation (SLK) eligible candidates may receive SLK or liver-alone transplant (LA) with access to kidney transplant after initial LA (KAL). We aimed to characterize SLK-eligible recipient outcomes according to treatment approach. Methods: This study utilized 2017–2023 SRTR data to identify SLK-eligible deceased donor liver transplants. Recipients were placed into two groups based on whether SLK was performed; non-SLK patients were sub-stratified into LA and KAL cohorts. After baseline comparisons, 2-year patient and graft survival outcomes were characterized by univariable and multivariable Cox proportional hazard regression and Kaplan–Meier analysis. Results: Among 4879 candidates identified, 3746 (76.8%) underwent SLK, 1023 (21.0%) LA, and 110 (2.3%) KAL. SLK recipients maintained the highest eGFRs at 6 months, 1 year, and 2 years post-transplant (p < 0.01). Compared to SLK recipients, non-SLK recipients had a higher 2-year risk of mortality (aHR 2.46, p < 0.01), all-cause events (aHR 1.91, p < 0.01), and liver graft failure (HR 1.55, p = 0.02). LA conferred a higher 2-year mortality risk (aHR 2.98, p < 0.01) and all-cause event risk (aHR 2.25, p < 0.01), while KAL had comparable mortality risk to SLK (aHR 0.43, p = 0.40). Conclusions: When SLK-eligible candidates undergo transplants, SLK remains the optimal path forward, even when a safety net kidney can be performed.
- 8 April 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (4) , e70533
Bridging Oceans and Distance: Excellent Long‐Term Outcomes in Non‐Mainland Kidney Transplantation
Purpose: Efforts to expand the kidney transplant (KT) donor pool have included geographic expansion of donation. We evaluated the outcomes after KT from organs procured outside of the continental United States (US). Methods: Adult kidney‐only deceased donor transplants from 2011 to 2022 in the United Network for Organ Sharing (UNOS) database were categorized by donor and recipient location (mainland to mainland US [MM], non‐mainland to mainland [NMM], and non‐mainland to non‐mainland [NMNM]). Recipient overall and event‐free survival were evaluated using time‐to‐event analysis and multivariable Cox regression. Results: There were 163 004 (98.5%) MM, 1351 (0.8%) NMM, and 1190 NMNM (0.7%) transplants, with non‐mainland donors from Puerto Rico (1233), Hawaii (806), Alaska (483), Bermuda (12), and the United States Virgin Islands (USVI) (7). Non‐mainland donors were older ( p < 0.001), had lower body mass index (BMI) ( p < 0.001), were less likely to have smoked cigarettes ( p < 0.001), had lower creatinine ( p < 0.001), and were less likely to donate after cardiac death ( p < 0.001) or utilize perfusion machines ( p < 0.001) compared to MM. NMM transplants traveled further between donor and recipient centers ( p < 0.001) and had longer cold ischemia times (CITs) (24.1 vs. 17.2 h, p < 0.001). There was no difference in acute rejection (adjusted odds ratio [aOR] 1.14, p = 0.59). NMM recipients had similar 1‐year (adjusted hazard ratio [aHR] = 0.87 [95% confidence interval (CI) 0.65–1.15], p = 0.32) and 5‐year (aHR = 0. 90 [95% CI 0.77–1.06], p = 0.19) event‐free survival and improved survival at 10 years (aHR = 0.83 [95% CI 0.72–0.95], p = 0.006) post‐transplant. Conclusion: Despite longer distances and CIT, select kidneys from NM donors can be successfully transplanted with excellent long‐term outcomes, including improved event‐free survival at 10 years post‐transplant. Use of NM donors should be encouraged to increase rates of KT.
- 8 April 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (4) , e70533
Bridging Oceans and Distance: Excellent Long‐Term Outcomes in Non‐Mainland Kidney Transplantation
Purpose: Efforts to expand the kidney transplant (KT) donor pool have included geographic expansion of donation. We evaluated the outcomes after KT from organs procured outside of the continental United States (US). Methods: Adult kidney‐only deceased donor transplants from 2011 to 2022 in the United Network for Organ Sharing (UNOS) database were categorized by donor and recipient location (mainland to mainland US [MM], non‐mainland to mainland [NMM], and non‐mainland to non‐mainland [NMNM]). Recipient overall and event‐free survival were evaluated using time‐to‐event analysis and multivariable Cox regression. Results: There were 163 004 (98.5%) MM, 1351 (0.8%) NMM, and 1190 NMNM (0.7%) transplants, with non‐mainland donors from Puerto Rico (1233), Hawaii (806), Alaska (483), Bermuda (12), and the United States Virgin Islands (USVI) (7). Non‐mainland donors were older ( p < 0.001), had lower body mass index (BMI) ( p < 0.001), were less likely to have smoked cigarettes ( p < 0.001), had lower creatinine ( p < 0.001), and were less likely to donate after cardiac death ( p < 0.001) or utilize perfusion machines ( p < 0.001) compared to MM. NMM transplants traveled further between donor and recipient centers ( p < 0.001) and had longer cold ischemia times (CITs) (24.1 vs. 17.2 h, p < 0.001). There was no difference in acute rejection (adjusted odds ratio [aOR] 1.14, p = 0.59). NMM recipients had similar 1‐year (adjusted hazard ratio [aHR] = 0.87 [95% confidence interval (CI) 0.65–1.15], p = 0.32) and 5‐year (aHR = 0. 90 [95% CI 0.77–1.06], p = 0.19) event‐free survival and improved survival at 10 years (aHR = 0.83 [95% CI 0.72–0.95], p = 0.006) post‐transplant. Conclusion: Despite longer distances and CIT, select kidneys from NM donors can be successfully transplanted with excellent long‐term outcomes, including improved event‐free survival at 10 years post‐transplant. Use of NM donors should be encouraged to increase rates of KT.
- 12 August 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 249, 116568
Outcomes of liver transplants utilizing donors from outside the contiguous United States
- 12 August 2025
- Published by Elsevier in The American Journal of Surgery
- Vol. 249, 116568
Outcomes of liver transplants utilizing donors from outside the contiguous United States
- Open Access
Outcomes of lung transplants utilizing donors from outside the continental United States
- Open Access
- 17 August 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (1) , 32-37
Moral injury: An unspoken burden of transplant surgery
- 17 August 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (1) , 32-37
Open AccessMoral injury: An unspoken burden of transplant surgery
- Open Access
- 21 February 2024
- Published by Elsevier in Journal of Liver Transplantation
- Vol. 14
Overcoming traditional barriers in living donor liver transplant
- 21 February 2024
- Published by Elsevier in Journal of Liver Transplantation
- Vol. 14
Open AccessOvercoming traditional barriers in living donor liver transplant
- 1 July 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 224 (1) , 250-256
The current status of the diversity pipeline in surgical training
- 1 July 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 224 (1) , 250-256
The current status of the diversity pipeline in surgical training